Amphastar Pharmaceuticals Inc
AMPH
Market Cap$2.05B
Close$
$76.49
79.3% upside
Current Fair Value
79.3% upsideUndervalued by 79.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.05 Billion |
|---|---|
| Enterprise Value | $2.38 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.6 |
| Beta | 0.87 |
| Outstanding Shares | 48,095,862 |
| Avg 30 Day Volume | 333,244 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 14.92 |
|---|---|
| PEG | 224.44 |
| Price to Sales | 3.28 |
| Price to Book Ratio | 3.28 |
| Enterprise Value to Revenue | 3.7 |
| Enterprise Value to EBIT | 12.23 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Amphastar Pharmaceuticals Inc
CEO: Jack Zhang